DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Raymond James Upgrades Ocular Therapeutix to Strong Buy, Raises Price Target to $15

Raymond James upgrades Ocular Therapeutix (NASDAQ:OCUL) from Outperform to Strong Buy and raises the price target from $7 to $15.

Benzinga · 03/03/2020 19:24

Raymond James upgrades Ocular Therapeutix (NASDAQ:OCUL) from Outperform to Strong Buy and raises the price target from $7 to $15.